patients with cystic fibrosis will have an alternative to nebulized tobramycin with the new Tobi Podhaler

Canadian patients with cystic fibrosis will have an alternative to nebulized tobramycin with the new Tobi Podhaler.

These patients usually have to take many nebulized drugs...bronchodilators, mucolytics, hypertonic saline, etc.

Nebulized therapy is needed to deliver large doses to the lungs...but nebulizers are cumbersome to use and time consuming.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote